Last month, the FDA took a much-anticipated step by issuing guidelines for drug makers that want to use social media, including examples of how to run paid search links on Google. Around the same time, the agency chastised one drug maker, Gilead Sciences, for a paid search link and the infraction offers an example of what the FDA does not want the pharmaceutical industry doing on social media.
Continue reading @ WSJ
No comments:
Post a Comment